ROS-Induced DNA Damage Associates with Abundance of Mitochondrial DNA in White Blood Cells of the Untreated Schizophrenic Patients
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
Authors: Chestkov, I. V.; Jestkova, E. M.; Ershova, E. S.; Golimbet, V. G.; Lezheiko, T. V.; Kolesina, N. Yu; Dolgikh, O. A.; Izhevskaya, V. L.; Kostyuk, G. P.; Kutsev, S. I.; Veiko, N. N.; Kostyuk, S. V.
Abstract
Objective. The aim of this study was (1) to examine the leukocyte mtDNA copy number (CN) in unmedicated (SZ (m-)) and medicated (SZ (m+)) male patients with paranoid schizophrenia (SZ) in comparison with the healthy male controls (HC) and (2) to compare the leukocyte mtDNA CN with the content of an oxidation marker 8-oxodG in lymphocytes of the SZ (m-) patients. Methods. We evaluated leukocyte mtDNA CN of 110 subjects with SZ in comparison with 60 male HC by the method qPCR (ratio mtDNA/nDNA (gene B2M) was detected). SZ patients were divided into two subgroups. The patients of the subgroups SZ (m+) (N = 55) were treated with standard antipsychotic medications in the hospital. The patients of the subgroup SZ (m-) (N = 55) were not treated before venous blood was sampled. To evaluate oxidative DNA damage, we quantified the levels of 8-oxodG in lymphocytes (flow cytometry) of SZ (m-) patients (N = 55) and HC (N = 30). Results. The leukocyte mtDNA CN showed no significant difference in SZ (m+) patients and HC. The mtDNA CN in the unmedicated subgroup SZ (m-) was significantly higher than that in the SZ (m+) subgroup or in HC group. The level of 8-oxodG in the subgroup SZ (m-) was significantly higher than that in HC group. Conclusion. The leukocytes of the unmedicated SZ male patients with acute psychosis contain more mtDNA than the leukocytes of the male SZ patients treated with antipsychotic medications or the healthy controls. MtDNA content positively correlates with the level of 8-oxodG in the unmedicated SZ patients.
Purification and identification of CD146 positive endometrial somatic stem cell from human normal endometrium biopsy and gene expression criteria
MINERVA BIOTECNOLOGICA
Authors: Heidari-Keshel, Saeed; Rezaei-Tavirani, Mostafa; Ai, Jafar; Soleimani, Masoud; Ebrahimi, Maryam; Baradaran-Rafii, Alireza; Zadeh, Saeid Rahman; Omidi, Roghiyeh; Rozafzoon, Reza; Zali, Hakimeh; Ghanbari, Zinat; Khoshzaban, Ahad
Abstract
BACKGROUND: The endometrial is answerable for the sex steroid hormones, endures tremendous growth in a cyclic manner, and is renewed and shed during a woman's lifetime. It has been recommended that the human endometrium may contain a population of stem cells that is responsible for its striking ability to regenerate. The aim of this study was the isolation and characterization of sub population stem cell in vitro condition from healthy donors. METHODS: Purification of endometrial stromal stem cell was acquired by selecting cells with magnetic bead sorting. The surface markers of stem cell were discerned by flow cytometry. Proliferation of endometrial stem cell was ascertained by MTT assay. The osteogenic potential was assessed by alizarin red staining, the adipogenic potential by oil red O staining and karyotyping were accomplished on human endometrial somatic stem cell. Then, appraised the specific genes of the osteogenic, adipogenic and stem cell were assessed by reverse transcription polymerase chain reaction (RT-PCR) and real time PCR method. RESULTS: Our data displayed that these cells had a negative expression of SSEA1, STAT3, CD34, CD45, CD133 and BMP4. On the other hand, they had a positive expression for Pou5f1, Nanog, Rex1, CD105, CD146, CD90, CD73 and B2m. Moreover, CD146 positive endometrial somatic stem cell showing normal karyotype is their ability to be continuously cultured for more than 20 passages. This cell has been differentiated to osteogenic and Adipogenic lineage. CONCLUSIONS: This study illustrates the presence of CD146 positive human endometrial somatic stem cell in the human endometrium and reveals their potential use in regenerative medicine and taming stem cell heterogeneity for cell therapy and tissue engineering, like in the treatment of related infertility diseases.